Dr. Erik Jason Reaves, D.O. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Unit 3230 Box 337, Dpo, AA 34031 Phone: 011-519-96720190 |
News Archive
Genmab A/S announced today that the net sales for Arzerra® (ofatumumab) during the fourth quarter of 2010 were GBP 9 million (approximately DKK 77 million).
As the House Democratic leadership continues to work toward moving a health overhaul measure to the floor, members continue to stake out positions - sometimes because of their personal histories or where they are from. In a few cases, the positions they have taken lead to increased attention.
Terminal metastatic cancer - the presently untreatable cause of the great majority of all cancer deaths - has now been effectively treated in three common fatal cancers in mice, announced Genomic Systems, citing research published online today in the Proceedings of the National Academy of Science (PNAS).
The Wall Street Journal: "Republicans are looking beyond Sunday's expected vote on the Democrats' health-care overhaul to focus on strategies for striking back should it pass, ranging from challenges to the measure by individual states to a national repeal campaign. ... GOP leaders hope at a minimum that they can energize conservative activists and turn the electorate against the Democrats in the crucial period after the law's enactment, when both parties would be fighting to define it in the public's mind before the November elections."
In a randomized clinical trial, SCOPE II, a new self-expanding bioprosthetic valve used in transcatheter aortic valve replacement (TAVR) failed to demonstrate non-inferiority compared to an existing self-expanding valve.
› Verified 6 days ago